SCHEMBL22963565

SCHEMBL22963565

CC1(C)OB(c2ccc3ccc4c5ccccc5ccc4c3n2)OC1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPRT1 P00492 3/20 0.41
▸ LPL P06858 2/20 0.39
▸ LIPG Q9Y5X9 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ CYP2A6 P11509 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ APEX1 P27695 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ PMP22 Q01453 1/20 0.34
▸ PAX8 Q06710 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31577401 1.00 HPRT1 (0.41) HPRT1LPLLIPGALDH1A1HSD17B10
SCHEMBL360716 0.92 LPL (0.42) HPRT1LPLLIPGALDH1A1HSD17B10
SCHEMBL14884190 0.86 CCR1 (0.41) LPLLIPGALDH1A1TDP1TSHR
SCHEMBL27343080 0.85 LPL (0.39) LPLLIPGALDH1A1HSD17B10TDP1
SCHEMBL14884191 0.85 CYP3A4 (0.36) HPRT1LPLLIPGALDH1A1TDP1
SCHEMBL14884167 0.84 CCR1 (0.42) LPLLIPGALDH1A1TDP1TSHR
SCHEMBL14884171 0.79 ALDH1A1 (0.36) LPLLIPGALDH1A1TDP1TSHR
SCHEMBL22963476 0.78 LPL (0.40) HPRT1LPLLIPGALDH1A1HSD17B10
SCHEMBL14884174 0.77 ALDH1A1 (0.38) LPLLIPGALDH1A1TDP1TSHR
SCHEMBL14884179 0.76 ALDH1A1 (0.34) LPLLIPGALDH1A1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250169357-A1 COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND DISPLAY DEVICE SK INC. (KR) 2025-05-22 — — US disclosed
US-20210043843-A1 COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-02-11 — — US disclosed
US-20210043843-A1 COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-02-11 — — US disclosed
US-9498481-B2 Cyclopropyl modulators of P2Y12 receptor AUSPEX PHARMACEUTICALS, INC. (US) 2016-11-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210043843-A1 COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND DISPLAY DEVICE ALDH1A2, L1CAM, OCIAD1 HPRT1 481/4885LPL 151/4885LIPG 268/4885
US-20250169357-A1 COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND DISPLAY DEVICE ALDH1A2, L1CAM, OCIAD1 HPRT1 481/4885LPL 151/4885LIPG 268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback